Gender differences in the determinants of willingness to get the COVID-19 vaccine among the working-age population in Japan

References

• Mahase E. Covid-19: pfizer vaccine efficacy was 52% after first dose and 95% after second dose, paper shows. Bmj. 2020;371:m4826. doi:10.1136/bmj.m4826.
   PubMed Web of Science ®Google Scholar
• Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. N Engl J Med. 2020;382:1969–73. doi:10.1056/NEJMp2005630.
   PubMed Web of Science ®Google Scholar
• Prime Minister of Japan and His Cabinet. Novel coronavirus vaccines. Tokyo. 2021 Feb 17 [accessed 2021 Apr 1]. https://japan.kantei.go.jp/ongoingtopics/vaccine.html#vaccine05.
   Google Scholar
• Furuse Y, Sando E, Tsuchiya N, Miyahara R, Yasuda I, Ko YK, Saito M, Morimoto K, Imamura T, Shobugawa Y, et al. Clusters of coronavirus disease in communities, Japan, January-April 2020. Emerg Infect Dis. 2020;26:2176–79. doi:10.3201/eid2609.202272.
   PubMed Web of Science ®Google Scholar
• Bartsch SM, O’Shea KJ, Ferguson MC, Bottazzi ME, Wedlock PT, Strych U, McKinnell JA, Siegmund SS, Cox SN, Hotez PJ, et al. Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention. Am J Prev Med. 2020;59:493–503. doi:10.1016/j.amepre.2020.06.011.
   PubMed Web of Science ®Google Scholar
• Sallam MCOVID-19. Vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021:9. doi:10.3390/vaccines9020160.
   PubMedGoogle Scholar
• de Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet. 2020;396:898–908. doi:10.1016/s0140-6736(20)31558-0.
   PubMed Web of Science ®Google Scholar
• Kuwabara N, Ching MS. A review of factors affecting vaccine preventable disease in Japan. Hawaii J Med Public Health. 2014;73:376–81.
   PubMedGoogle Scholar
• Hori A, Yoshii S, Isaka Y, Wada K. Factors associated with participation in an ongoing national catch-up campaign against rubella: a cross-sectional internet survey among 1680 adult men in Japan. BMC Public Health. 2021;21:292. doi:10.1186/s12889-021-10340-8.
   PubMed Web of Science ®Google Scholar
• Wada K, Smith DR. Mistrust surrounding vaccination recommendations by the Japanese government: results from a national survey of working-age individuals. BMC Public Health. 2015;15:426. doi:10.1186/s12889-015-1772-8.
   PubMed Web of Science ®Google Scholar
• Wada K, Smith DR. Influenza vaccination uptake among the working age population of Japan: results from a national cross-sectional survey. PLoS One. 2013;8:e59272. doi:10.1371/journal.pone.0059272.
   PubMed Web of Science ®Google Scholar
• Bonanni P, Zanella B, Santomauro F, Lorini C, Bechini A, Boccalini S. Safety and perception: what are the greatest enemies of HPV vaccination programmes? Vaccine. 2018;36:5424–29. doi:10.1016/j.vaccine.2017.05.071.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Sukegawa A, Nishikawa A, Kubota K, Motoki Y, Asai-Sato M, Ueda Y, Sekine M, Enomoto T, Hirahara F, et al. Current knowledge of and attitudes toward human papillomavirus-related disease prevention among Japanese: a large-scale questionnaire study. J Obstet Gynaecol Res. 2019;45:994–1005. doi:10.1111/jog.13929.
   PubMed Web of Science ®Google Scholar
• Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495. doi:10.1016/j.eclinm.2020.100495.
   PubMedGoogle Scholar
• Wang K, Wong EL, Ho KF, Cheung AW, Yau PS, Dong D, Wong SY, Yeoh EK. Change of willingness to accept COVID-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in Hong Kong, China: repeated cross-sectional surveys. Vaccines (Basel). 2021:9. doi:10.3390/vaccines9010062.
   PubMed Web of Science ®Google Scholar
• Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine. 2020;38:6500–07. doi:10.1016/j.vaccine.2020.08.043.
   PubMed Web of Science ®Google Scholar
• Chen M, Li Y, Chen J, Wen Z, Feng F, Zou H, Fu C, Chen L, Shu Y, Sun C. An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination. Hum Vaccin Immunother. 2021:1–10. doi:10.1080/21645515.2020.1853449.
   Web of Science ®Google Scholar
• Dodd RH, Cvejic E, Bonner C, Pickles K, McCaffery KJ. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2020:30559–4. doi:10.1016/s1473-3099(20.
   Web of Science ®Google Scholar
• Yoda T, Katsuyama H. Willingness to receive COVID-19 vaccination in Japan. Vaccines (Basel). 2021:9. doi:10.3390/vaccines9010048.
   PubMedGoogle Scholar
• Fujino Y, Ishimaru T, Eguchi H, Tsuji M, Tateishi S, Ogami A, Mori K, Matsuda S. Protocol for a nationwide internet-based health survey in workers during the COVID-19 pandemic in 2020. JUOEH. 2021;43:517–25. doi:10.7888/juoeh.43.217.
   Google Scholar
• Looi MK. Covid-19: Japan declares second state of emergency as Asia struggles with virus surge. Bmj. 2021;372:n141. doi:10.1136/bmj.n141.
   PubMed Web of Science ®Google Scholar
• Baraniuk C. Covid-19: how the UK vaccine rollout delivered success, so far. Bmj. 2021;372:n421. doi:10.1136/bmj.n421.
   PubMed Web of Science ®Google Scholar
• Organisation for Economic Co-operation and Development. Exchange rates. Palis. 2021 [accessed 2021 Apr 1]. https://data.oecd.org/conversion/exchange-rates.htm?fbclid=IwAR2Bn6JlF8WfAbVhwDEiKFhG0_rsTu-iLq1PW47o1ujebwc7CWF0e0wUx_A.
   Google Scholar
• Alley SJ, Stanton R, Browne M, To QG, Khalesi S, Williams SL, Thwaite TL, Fenning AS, Vandelanotte C. As the pandemic progresses, how does willingness to vaccinate against COVID-19 evolve? Int J Environ Res Public Health. 2021;18. doi:10.3390/ijerph18020797.
   Web of Science ®Google Scholar
• Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, Schreyögg J, Stargardt T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21:977–82. doi:10.1007/s10198-020-01208-6.
   PubMed Web of Science ®Google Scholar
• Byrnes JP, Miller DC, Schafer WD. Gender differences in risk taking: a meta-analysis. Psychol Bull. 1999;125:367–83. doi:10.1037/0033-2909.125.3.367.
   Web of Science ®Google Scholar
• Unroe KT, Evans R, Weaver L, Rusyniak D, Blackburn J. Willingness of long-term care staff to receive a COVID-19 vaccine: a single state survey. J Am Geriatr Soc. 2020. doi:10.1111/jgs.17022.
   Web of Science ®Google Scholar
• Graffigna G, Palamenghi L, Boccia S, Barello S. Relationship between citizens’ health engagement and intention to take the COVID-19 vaccine in Italy: a mediation analysis. Vaccines (Basel). 2020:8. doi:10.3390/vaccines8040576.
   PubMed Web of Science ®Google Scholar
• Tsuda K, Yamamoto K, Leppold C, Tanimoto T, Kusumi E, Komatsu T, Kami M. Trends of media coverage on human papillomavirus vaccination in Japanese newspapers. Clin Infect Dis. 2016;63:1634–38. doi:10.1093/cid/ciw647.
   PubMed Web of Science ®Google Scholar
• Sakamoto A, Chanyasanha C, Sujirarat D, Matsumoto N, Nakazato M. Factors associated with pneumococcal vaccination in elderly people: a cross-sectional study among elderly club members in Miyakonojo City, Japan. BMC Public Health. 2018;18:1172. doi:10.1186/s12889-018-6080-7.
   PubMed Web of Science ®Google Scholar
• Yi S, Nonaka D, Nomoto M, Kobayashi J, Mizoue T. Predictors of the uptake of A (H1N1) influenza vaccine: findings from a population-based longitudinal study in Tokyo. PLoS One. 2011;6:e18893. doi:10.1371/journal.pone.0018893.
   PubMed Web of Science ®Google Scholar
• Nguyen T, Henningsen KH, Brehaut JC, Hoe E, Wilson K. Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public. Infect Drug Resist. 2011;4:197–207. doi:10.2147/idr.s23174.
   PubMedGoogle Scholar
• Iwasa T, Wada K. Reasons for and against receiving influenza vaccination in a working age population in Japan: a national cross-sectional study. BMC Public Health. 2013;13:647. doi:10.1186/1471-2458-13-647.
   PubMed Web of Science ®Google Scholar
• Matsui D, Shigeta M, Ozasa K, Kuriyama N, Watanabe I, Watanabe Y. Factors associated with influenza vaccination status of residents of a rural community in Japan. BMC Public Health. 2011;11:149. doi:10.1186/1471-2458-11-149.
   PubMed Web of Science ®Google Scholar
• Klimek L, Novak N, Hamelmann E, Werfel T, Wagenmann M, Taube C, Bauer A, Merk H, Rabe U, Jung K, et al. Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: position statement of the German Allergy Societies: medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA). Allergo J Int. 2021;30:51–55. doi:10.1007/s40629-020-00160-4.
   PubMedGoogle Scholar
• Loomba S, de Figueiredo A, Piatek SJ, de Graaf K, Larson HJ. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nature Human Behav. 2021;5:337–48. doi:10.1038/s41562-021-01056-1.
   PubMed Web of Science ®Google Scholar
• Davies P, Chapman S, Leask J. Antivaccination activists on the world wide web. Arch Dis Child. 2002;87:22–25. doi:10.1136/adc.87.1.22.
   PubMed Web of Science ®Google Scholar